Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys
- 18 December 1995
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 363 (3), 345-358
- https://doi.org/10.1002/cne.903630302
Abstract
Effects of a single injection of either 150 μg human recombinant glial cell line‐derived neurotrophic factor (rGDNF) or vehicle into the right substantia nigra were analyzed in 12 normal adult female rhesus monkeys. The studies included evaluating whole animal behavior, electrochemical recordings of striatal dopamine release, neurochemical determinations of basal ganglia and nigral monoamine levels, and immunohistochemical staining of the nigrostriatal dopamine system. The behavioral effects over the 3–week observation period following trophic factor administration were small, with blinded observers unable to distinguish between GDNF and vehicle‐treated animals. Quantitative measurements did show that five of six trophic factor recipients experienced some weight loss and four of the six GDNF recipients displayed small, but significant, increases in daytime activity levels. In vivo electrochemical recordings in the ipsilateral caudate and putamen 3 weeks after GDNF administration revealed increased potassium‐evoked release of dopamine in trophic factor recipients. In a second series of animals killed at the same time, dopamine levels in the substantia nigra and ventral tegmental area of GDNF recipients were significantly increased, with ipsilateral values more than 200% higher than contralateral and control levels. Levels of the dopamine metabolite HVA were significantly elevated in the substantia nigra, ventral tegmental area, and caudate nucleus ipsilateral to the trophic factor injection. There was a trend toward increased HVA levels in the ipsilateral putamen, nucleus accumbens, and globus pallidus in GDNF‐treated animals, but the ratios of HVA to dopamine were not significantly different between vehicle‐ and GDNF‐treated recipients. Although some tissue damage from the delivery of concentrated trophic factor was evident, dopamine neurons remained in and adjacent to the injection site. In the substantia nigra ipsilateral to GDNF administration, dopamine‐neuron perikaryal size was significantly increased, along with a significant increase in tyrosine hydroxylase‐positive axons and dendrites. We conclude that, in the adult rhesus monkey, a single intranigral GDNF injection induces a significant upregulation of mesencephalic dopamine neurons which lasts for weeks.Keywords
This publication has 39 references indexed in Scilit:
- In Vivo Electrochemical Studies of Dopamine Overflow and Clearance in the Striatum of Normal and MPTP‐Treated Rhesus MonkeysJournal of Neurochemistry, 1996
- Glial cell line‐derived neurotrophic factor stimulates fiber formation and survival in cultured neurons from peripheral autonomic gangliaJournal of Neuroscience Research, 1995
- Neuron saving schemesNature, 1995
- Reversal of hemiparkinsonian syndrome in nonhuman primates by amnion implantation into caudate nucleusJournal of Neurosurgery, 1994
- Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivoNeuroscience Letters, 1994
- The effect of systemically administered recombinant human nerve growth factor in healthy human subjectsAnnals of Neurology, 1994
- Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neuronsAnnals of Neurology, 1994
- Immunocytochemical Quantification of Tyrosine Hydroxylase at a Cellular Level in the Mesencephalon of Control Subjects and Patients with Parkinson's and Alzheimer's DiseaseJournal of Neurochemistry, 1993
- In Vivo Electrochemical Measurements of Exogenous Dopamine Clearance in Normal and Neonatal 6-Hydroxydopamine-Treated Rat StriatumExperimental Neurology, 1993
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993